James P. Boylan

Insider Reports History

Entity
Individual
Location
C/O Enavate Sciences, 2884 Sand Hill Rd., Ste 100, Menlo Park, CA
Signature
By: /s/ Thomas Danielski, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James P. Boylan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Compass Therapeutics, Inc. Director Stock Option (Right to Buy) 40K Mar 8, 2024 Direct
Zenas BioPharma, Inc. Director Stock Option (Right to Buy) 37K Sep 12, 2024 Direct
Immunome Inc. Director Stock option (right to buy) 11.3K Jun 13, 2024 Direct

Insider Reports Filed by James P. Boylan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAMP Camp4 Therapeutics Corp Oct 10, 2024 0 $0 3 Oct 10, 2024 Director
ZBIO Zenas BioPharma, Inc. Sep 12, 2024 1 $0 4 Sep 16, 2024 Director
ZBIO Zenas BioPharma, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director
IMNM Immunome Inc. Jun 13, 2024 1 $0 4 Jun 18, 2024 Director
CMPX Compass Therapeutics, Inc. Mar 8, 2024 1 $0 4 Mar 11, 2024 Director
IMNM Immunome Inc. Oct 27, 2023 1 $0 4 Oct 31, 2023 Director
IMNM Immunome Inc. Oct 2, 2023 0 $0 3 Oct 12, 2023 Director
CMPX Compass Therapeutics, Inc. Nov 4, 2022 0 $0 3 Nov 10, 2022 Director